Proposed Spray Sunscreen Warnings A Gateway For Nano Tort Litigation?
This article was originally published in The Rose Sheet
Executive Summary
FDA’s proposed warnings for inclusion on spray sunscreen product labeling could open the door to tort litigation, according to Jennifer Quinn-Barabanov, a partner and product liability specialist at Steptoe & Johnson, LLP.
You may also be interested in...
FDA Questions Spray Sunscreen Safety, Efficacy & Monograph Status
FDA could exclude increasingly popular spray sunscreens from the final monograph unless firms submit sufficient safety and efficacy data, according to an advanced notice of proposed rulemaking.
FDA Strengthens Sunscreen Testing And Label Requirements
As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.